Revealing genetic and cellular mechanisms of Crohn’s disease
New Mount Sinai study identifies a novel approach for tailored treatment that could be more effective for patients
Crohn's disease
Tiziana collaborates with Parexel on Crohn’s
Tiziana and Parexel will conduct Phase 1b/2 study of take-home capsules of Foralumab, an anti-CD3 monoclonal antibody
Conquering Crohn’s disease
Promising Phase 3 test results give hope for those with the gastrointestinal disorder
